CD8A and neoplasm: Such a “one stone and two birds” effect of NK checkpoint therapy was recently suggested in TIGIT blockage therapy, which simultaneously prevents NK cell exhaustion and restores CD8+ T cell-mediated anti-tumor immunity61, albeit NK-T interaction mechanism has not been described.